Clofenciclan

Clofenciclan (Chlorphencyclan; Tonquil, Vesitan) is a dopamine-releasing agent developed by Boehringer & Soehne in the 1950s.[1] It proved unpopular as a treatment because of its pronounced stimulant activity.[2]

Not to be confused with Clofenamide.
Clofenciclan
Clinical data
Routes of
administration		Oral
ATC code
  • none
Identifiers
IUPAC name
  • 2-[1-(4-chlorophenyl)cyclohexyl]oxy-N,N-diethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H28ClNO
Molar mass309.874 g·mol−1
3D model (JSmol)
SMILES
  • ClC1=CC=C(C2(CCCCC2)OCCN(CC)CC)C=C1
InChI
  • InChI=1S/C18H28ClNO/c1-3-20(4-2)14-15-21-18(12-6-5-7-13-18)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15H2,1-2H3 Y
  • Key:FFCARBNHUSWRGK-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

See also

References
  1. U.S. Patent 3,254,083
  2. Poeldinger W (January 1962). "[Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry]". Praxis (in German). 51: 73–8. PMID 14487367.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.